Technology
Health
Biotechnology

NantKwest

$1.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (3.92%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NantKwest and other stocks, options, ETFs, and crypto commission-free!

About

NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. Read More The firm operates through the following geographical segments: United States; Europe; and Other Non-U.S. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA.

Employees
161
Headquarters
San Diego, California
Founded
2002
Market Cap
104.59M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
378.30K
High Today
$1.07
Low Today
$1.03
Open Price
$1.04
Volume
62.04K
52 Week High
$4.23
52 Week Low
$0.93

Collections

Technology
Health
Biotechnology
Cancer Prevention
2015 IPO
US
North America

News

Yahoo FinanceMay 1

Brink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92® Cells

SAN DIEGO--(BUSINESS WIRE)-- NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics and Related Biological Products Brink Biologics, Inc., a NantKwest, Inc. (NK) affiliate who serves as exclusively-licensed distributor of NantKwest’s proprietary NK-92® natural killer cells, offers a variety of research grade aNK™ and haNK® cell lines for non-clinical laboratory use in discovery, translational and developmen...

188

Earnings

-$0.37
-$0.33
-$0.28
-$0.24
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.25 per share
Actual
Expected Jun 3, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.